VOGLISLOW G3 M 0.3

If you have lived with type 2 diabetes for a few years, you may have noticed that the treatment plan rarely stays the same. A single tablet that worked well at the start often stops being enough. Fasting sugar begins to creep up, the pancreas releases less insulin than before, and a plate of rice, roti or a festive sweet can send the glucometer reading high two hours later. This is why many doctors in India combine medicines that act in different ways. VOGLISLOW G3 M 0.3 from Steris Healthcare Pvt. Ltd. is one such triple-combination tablet. It brings together glimepiride, voglibose and metformin hydrochloride. This guide explains what it contains, why it matters, its benefits, precautions and side effects, and how to buy it responsibly.

Product Information 

Brand Name: VOGLISLOW G3 M 0.3
Composition: Voglibose 0.3 mg + Glimepiride 3 mg + Metformin Hydrochloride 500 mg
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd.
Dosage Form: Tablet
Pack Size: 15 tablets
Drug Classes: Alpha-glucosidase inhibitor + sulfonylurea + biguanide
Therapeutic Category: Anti-diabetic (oral combination therapy)
Prescription Status: Prescription required (Rx)
Primary Use: Management of type 2 diabetes mellitus in adults when blood sugar is not adequately controlled with one or two anti-diabetic agents
Target Market: India
Search Term People Use: glimepiride voglibose and metformin hydrochloride tablets

Please check the printed label and leaflet on your pack for the exact metformin form (immediate or sustained release), batch number, manufacturing and expiry dates, MRP and storage instructions. Prices vary by pharmacy and location, so confirm the current price when you buy.

What Is VOGLISLOW G3 M 0.3?

VOGLISLOW G3 M 0.3 is a fixed-dose combination of three well-established anti-diabetic ingredients. Each one targets a different part of the blood sugar problem. In the brand name, “G3” points to glimepiride 3 mg, “M” to metformin and “0.3” to voglibose 0.3 mg.

Glimepiride (3 mg) is a sulfonylurea. It stimulates the beta cells of the pancreas to release more insulin, which lowers blood sugar, particularly around meals. Because it increases insulin release, it can cause low blood sugar if meals are delayed or skipped. A 3 mg strength is a relatively higher dose, so it is usually intended for people whose doctors have already judged that they need it.

Metformin Hydrochloride (500 mg) is a biguanide and the most widely used first-line drug for type 2 diabetes. It reduces the amount of glucose released by the liver and improves how muscle and fat tissue respond to insulin.

Voglibose (0.3 mg) is an alpha-glucosidase inhibitor. It works in the small intestine and slows the digestion of complex carbohydrates, so glucose enters the blood gradually instead of surging right after eating.

Together, the three ingredients address insulin availability, insulin resistance and post-meal glucose absorption in one tablet.

Why It Is Important

1. Type 2 diabetes is progressive. Over the years, insulin production tends to decline. Many patients need two or three medicines to stay within their HbA1c target. A triple combination can be a practical step when two drugs no longer maintain control.

2. It works on several causes at once. Insulin resistance, reduced insulin secretion and rapid carbohydrate absorption all contribute to high sugar. This tablet acts on each of them.

3. Post-meal spikes are easy to miss and costly over time. Repeated high glucose after meals can contribute to damage in the eyes, kidneys, nerves and blood vessels. Voglibose is specifically useful in softening these spikes.

4. It suits carbohydrate-rich Indian diets. Rice, wheat, potatoes, sweets and snacks make up a large share of daily calories in many households, which makes post-meal control especially relevant.

5. It can improve adherence. Research on chronic conditions consistently shows that simpler regimens are easier to follow. One tablet in place of three can reduce missed doses, particularly for older adults and busy working professionals.

6. It may reduce pill burden and cost. For some patients, a single combination tablet is more convenient and can be more economical than three separate medicines.

7. It supports long-term complication prevention. Keeping HbA1c within the target set by your doctor lowers the risk of neuropathy, retinopathy, kidney disease and cardiovascular problems.

Key Benefits 

• Stronger overall glycaemic control: Three complementary mechanisms help lower fasting and post-meal glucose when the tablet is used as prescribed.
• Reduced post-meal glucose rise: Voglibose delays carbohydrate absorption and flattens peaks.
• Improved insulin sensitivity: Metformin helps the body use its own insulin more effectively.
• Enhanced insulin release: Glimepiride stimulates the pancreas, which helps when natural insulin production has fallen.
• Convenience: One tablet instead of three simplifies the daily routine.
• Established ingredients: Each component has been used for many years in India and around the world, so doctors have considerable experience with them.
• Useful step-up option: Doctors often consider a triple combination when monotherapy or dual therapy no longer keeps blood sugar at target.

No tablet works in isolation. Results are best when medicine is combined with a balanced diet, regular physical activity, adequate sleep, weight management and routine glucose monitoring.

Precautions: What to Tell Your Doctor and Keep in Mind

Do not use this medicine if you:

• Have type 1 diabetes, diabetic ketoacidosis or diabetic coma
• Are allergic to glimepiride, voglibose, metformin, or to sulfonylurea or sulfonamide medicines
• Have severe kidney impairment or serious liver disease
• Have conditions that raise the risk of lactic acidosis, such as severe infection, dehydration, serious heart or lung failure, or heavy alcohol use
• Have intestinal obstruction, severe inflammatory bowel disease or chronic digestive disorders affecting absorption

Use with caution and under medical supervision if you:

• Are elderly, because the risk of low blood sugar is higher
• Have mild to moderate kidney or liver problems
• Eat irregularly or skip meals often
• Have G6PD deficiency, since sulfonylureas can rarely cause haemolysis in such patients
• Have had abdominal surgery or bowel problems
• Are scheduled for surgery or a scan using contrast dye, as metformin may need to be paused temporarily
• Are pregnant, planning pregnancy or breastfeeding. This type of combination is generally not recommended, and your doctor may suggest insulin or another suitable option
• Take other medicines such as insulin, beta-blockers, certain antibiotics, fluconazole, NSAIDs, steroids, diuretics or herbal supplements, as these can change how the medicine acts

Possible Side Effects

Most people tolerate these medicines well, but side effects can occur, especially during the first few weeks.

Common side effects:

• Gas, flatulence and abdominal bloating (more typical with voglibose)
• Stomach discomfort or cramps
• Nausea, loose stools or diarrhoea
• Metallic taste in the mouth (metformin)
• Mild headache or dizziness
• Reduced appetite

Less common but important:

• Low blood sugar (hypoglycaemia), mainly due to glimepiride
• Weight gain (a sulfonylurea effect)
• Skin rash, itching or allergic reactions
• Constipation
• Vitamin B12 deficiency with long-term metformin use
• Changes in liver enzyme levels on blood tests

Frequently Asked Questions

1. What are glimepiride voglibose and metformin hydrochloride tablets?

Glimepiride, voglibose and metformin hydrochloride tablets are a fixed-dose combination anti-diabetic medicine used for adults with type 2 diabetes mellitus. They combine three drugs that work in different ways: metformin lowers glucose release from the liver and improves insulin sensitivity, glimepiride stimulates the pancreas to release more insulin, and voglibose slows carbohydrate absorption in the gut to reduce post-meal sugar spikes. Doctors usually prescribe this combination when one or two medicines are not keeping blood sugar within target. It is a prescription-only medicine.

2. What is the composition of glimepiride voglibose metformin tablets?

TRIOGLIMITERIS 1/0.2 contains:

• Voglibose 0.2 mg
• Glimepiride 1 mg
• Metformin Hydrochloride 500 mg

Other strengths of this combination may exist from different brands, so always check the label for the exact composition.

3. Which company manufactures glimepiride voglibose metformin tablets in India?

TRIOGLIMITERIS 1/0.2 is manufactured and marketed by Steris Healthcare Pvt. Ltd. Several other Indian pharmaceutical companies also market this combination under their own brand names. Confirm the manufacturer name, batch number and licence details printed on the pack.

4. Where can I find a supplier of glimepiride voglibose metformin tablets?

You can source these tablets through:

• Licensed retail chemists and hospital pharmacies (for personal use with a prescription)
• Registered pharmaceutical wholesalers and distributors
• Licensed online pharmacies that display a valid drug licence number
• The manufacturer directly, through its official website or business contact channels

Always verify the supplier’s drug licence (retail or wholesale), GST registration and physical address before ordering. Avoid sellers who do not ask for a prescription for retail purchases or who cannot show valid licences.

5. How can I buy glimepiride voglibose metformin tablets in bulk?

Bulk purchase is typically done through a licensed wholesaler, distributor or directly from the manufacturer or its authorised marketing team. Buyers such as pharmacies, hospitals, clinics and distributors usually need to provide:

• A valid wholesale or retail drug licence
• GST number and business details
• Required quantity and preferred pack size (for example, 15 tablets per strip)
• Delivery location

Ask for a proper tax invoice, batch details and expiry dates with every consignment. Individual patients should not buy in bulk without a doctor’s advice, because tablets have expiry dates and a prescription is required.

6. What is the price of glimepiride voglibose metformin tablets?

The price depends on the brand, strength, pack size, pharmacy and location. TRIOGLIMITERIS 1/0.2 is available in a pack of 15 tablets, and the printed MRP on the pack is the maximum retail price. Wholesale rates and discounts for bulk orders differ by supplier and order quantity. Please confirm the current price with the manufacturer, your local chemist or a licensed distributor, as prices can change.

7. Can pharmaceutical distributors order these tablets wholesale?

Yes, licensed pharmaceutical distributors and wholesalers can generally place wholesale orders with the manufacturer or its authorised channels. You will usually need to share your wholesale drug licence, GST details and territory or business information. Terms such as minimum order quantity, margins, credit period and delivery timelines are set by the company, so contact the marketer directly to discuss them.

8. Which pharmaceutical companies offer third-party manufacturing for these tablets?

Many Indian contract and loan-licence manufacturers produce oral anti-diabetic combinations for other brands, especially in pharma hubs such as Baddi, Himachal Pradesh; Haridwar, Uttarakhand; Ahmedabad and Vadodara, Gujarat; and Hyderabad, Telangana. Since I cannot verify which specific companies currently offer this exact combination, I recommend you:

• Check that the manufacturer holds a valid manufacturing licence and WHO-GMP or equivalent certification
• Ask for product-specific capability, minimum order quantity and stability data
• Review regulatory documents and visit the facility or request an audit where possible
• Confirm the combination’s approval status with the Indian drug regulator

Third-party manufacturing of a prescription fixed-dose combination must comply with CDSCO and state drug regulations.

9. How can I request a quotation for glimepiride voglibose metformin tablets?

To request a quotation, contact the manufacturer or a licensed supplier through their official email, phone number or enquiry form and include:

• Your company name and business type (distributor, pharmacy, hospital, etc.)
• Drug licence and GST numbers
• Product name and composition (Voglibose 0.2 mg, Glimepiride 1 mg, Metformin Hydrochloride 500 mg)
• Pack size and required quantity
• Delivery location and expected timeline

Request the quote in writing, and ask for the validity period, payment terms and applicable taxes.

10. Where can I find the product specifications for these tablets?

Product specifications are available from:

• The pack label and the package insert (leaflet) inside the carton
• The manufacturer’s official website or product catalogue
• The marketer’s sales or regulatory team on request
• Your pharmacist or prescribing doctor

Key details to check include composition, dosage form (tablet), pack size, storage conditions, shelf life, batch number and manufacturing and expiry dates. Distributors and institutional buyers can also request a product data sheet or certificate of analysis from the manufacturer.